World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 114 4621 4334 2508 2322 507 78374

Donald A. Berry publications per year

The chart shows the history of publications by Donald A. Berry between 1964 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Donald A. Berry published across 62 years, from 1964 to 2025, averaging 11 papers a year. Output peaked at 58 publications in 2023. 36 of the 683 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1964 to 2025. Vertical axis: number of publications, 0 to 58. Peak 58 publications in 2023. 1964: 1 publication 1965: 0 publications 1966: 0 publications 1967: 0 publications 1968: 0 publications 1969: 0 publications 1970: 0 publications 1971: 0 publications 1972: 1 publication 1973: 1 publication 1974: 3 publications 1975: 0 publications 1976: 0 publications 1977: 1 publication 1978: 2 publications 1979: 2 publications 1980: 3 publications 1981: 1 publication 1982: 2 publications 1983: 3 publications 1984: 2 publications 1985: 9 publications 1986: 2 publications 1987: 5 publications 1988: 2 publications 1989: 5 publications 1990: 3 publications 1991: 5 publications 1992: 3 publications 1993: 3 publications 1994: 9 publications 1995: 8 publications 1996: 3 publications 1997: 9 publications 1998: 16 publications 1999: 10 publications 2000: 8 publications 2001: 8 publications 2002: 10 publications 2003: 14 publications 2004: 16 publications 2005: 28 publications 2006: 19 publications 2007: 19 publications 2008: 13 publications 2009: 24 publications 2010: 23 publications 2011: 19 publications 2012: 27 publications 2013: 16 publications 2014: 23 publications 2015: 35 publications 2016: 22 publications 2017: 23 publications 2018: 24 publications 2019: 19 publications 2020: 31 publications 2021: 27 publications 2022: 27 publications 2023: 58 publications 2024: 31 publications 2025: 5 publications
1964 2025

683 publications in total across all disciplines

View publications per year as a table
Donald A. Berry: publications per year, 1964 to 2025
Year Publications
1964 1
1965 0
1966 0
1967 0
1968 0
1969 0
1970 0
1971 0
1972 1
1973 1
1974 3
1975 0
1976 0
1977 1
1978 2
1979 2
1980 3
1981 1
1982 2
1983 3
1984 2
1985 9
1986 2
1987 5
1988 2
1989 5
1990 3
1991 5
1992 3
1993 3
1994 9
1995 8
1996 3
1997 9
1998 16
1999 10
2000 8
2001 8
2002 10
2003 14
2004 16
2005 28
2006 19
2007 19
2008 13
2009 24
2010 23
2011 19
2012 27
2013 16
2014 23
2015 35
2016 22
2017 23
2018 24
2019 19
2020 31
2021 27
2022 27
2023 58
2024 31
2025 5
Total 683
Download as CSV

Donald A. Berry publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Donald A. Berry sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 501–520 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 507 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617 507
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Donald A. Berry D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Donald A. Berry sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 114–115 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 114 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393 114
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Research.com Recognitions

  • 1990 - Fellow of Alfred P. Sloan Foundation
  • 1986 - Fellow of the American Statistical Association (ASA)

Overview

Donald A. Berry is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with a particular emphasis on oncology and cancer research.

Their published work spans several subfields including oncology, cancer research, statistics and probability, radiology, nuclear medicine and imaging, as well as pulmonary and respiratory medicine. The main topics addressed in their research include breast cancer treatment studies, cancer genomics and diagnostics, statistical methods in clinical trials, cancer treatment and pharmacology, HER2/EGFR in cancer research, radiomics and machine learning in medical imaging, and advanced breast cancer therapies.

Some of the recent papers authored or co-authored by Donald A. Berry are:

  • "A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody" (2021, Alzheimer s Research & Therapy)
  • "Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer" (2020, JAMA Oncology)
  • "Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia" (2020, JAMA Oncology)
  • "Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery" (2021, The Lancet Oncology)
  • "Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial" (2021, Cancer Cell)

Frequent co-authors collaborating with Donald A. Berry include:

  • Laura J. Esserman
  • Christina Yau
  • Angela DeMichele
  • Douglas Yee
  • Nola M. Hylton

The scientist has published extensively in several key venues, notably:

  • Journal of Clinical Oncology
  • Cancer Research
  • UNC Libraries
  • Neuro-Oncology
  • Clinical Cancer Research

Their contributions have been recognized through awards such as:

  • Fellow of Alfred P. Sloan Foundation (1990)
  • Fellow of the American Statistical Association (ASA) (1986)

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer

    Donald A. Berry;Kathleen A. Cronin;Sylvia Plevritis;Dennis G. Fryback

  • Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

    Marc L. Citron;Donald A. Berry;Constance Cirrincione;Clifford Hudis

  • Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

    I. Craig Henderson;Donald A. Berry;George D. Demetri;Constance T. Cirrincione

  • Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

    S. Eva Singletary;Craig Allred;Pandora Ashley;Lawrence W. Bassett

  • Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

    Aman U. Buzdar;Nuhad K. Ibrahim;Deborah Francis;Daniel J. Booser

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    Joe Y Chang;Suresh Senan;Marinus A. Paul;Reza John Mehran

  • Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review

    Peter B. Bach;Joshua N. Mirkin;Thomas K. Oliver;Christopher G. Azzoli

  • Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial

    David J. Wilber;Carlo Pappone;Petr Neuzil;Angelo De Paola

  • The decrease in breast-cancer incidence in 2003 in the United States

    Peter M. Ravdin;Kathleen A. Cronin;Nadia Howlader;Christine D. Berg

  • c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer

    Hyman B. Muss;Ann D. Thor;Donald A. Berry;Timothy Kute

  • Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343

    Kevin S. Hughes;Lauren A. Schnaper;Jennifer R. Bellon;Constance T. Cirrincione

  • Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer

    Kevin S. Hughes;Lauren A. Schnaper;Donald Berry;Constance Cirrincione

  • Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

    William M. Sikov;Donald A. Berry;Charles M. Perou;Baljit Singh

  • Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

    Donald A. Berry;Constance Cirrincione;I. Craig Henderson;Marc L. Citron

  • Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2

    Giovanni Parmigiani;Donald A. Berry;Omar Aguilar

  • Meta-analyses of Colorectal Cancer Risk Factors

    Constance M. Johnson;Caimiao Wei;Joe E. Ensor;Derek J. Smolenski

  • HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

    Daniel F. Hayes;Ann D. Thor;Lynn G. Dressler;Donald Weaver

  • Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

    Daniel R. Budman;Donald A. Berry;Constance T. Cirrincione;I. Craig Henderson

Frequent Co-Authors

Laura J. Esserman
Laura J. Esserman University of California, San Francisco
Christina Yau
Christina Yau University of California, San Francisco
Eric P. Winer
Eric P. Winer Yale University
Angela DeMichele
Angela DeMichele University of Pennsylvania
Laura J. van't Veer
Laura J. van't Veer University of California, San Francisco
Clifford A. Hudis
Clifford A. Hudis Memorial Sloan Kettering Cancer Center
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Kathy S. Albain
Kathy S. Albain Loyola University Chicago
Douglas Yee
Douglas Yee University of Minnesota
Judy C. Boughey
Judy C. Boughey Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering a career in Medicine or related fields in the USA, a variety of online degree options can help jumpstart your journey—or advance your expertise. These pathways offer flexibility, affordability, and specialization, making them popular choices for students and working professionals alike.

Aspiring practical nurses looking for convenient study formats may consider an lpn program, which allows you to start working in healthcare quickly due to its focused and accelerated curriculum. If your interest is in leadership, management, or healthcare business operations, consider the cheapest online healthcare administration degree to gain essential organizational skills while controlling costs.

Nurses aiming for higher qualifications often pursue a Doctor of Nursing Practice through dnp programs without dissertation, ideal for those who want to focus on clinical practice rather than heavy research. Additionally, mental health is an essential field in medicine today, and the psych np programs provide an accelerated route to specialize in psychiatric and mental health care. Together, these pathways widen opportunities in healthcare beyond the traditional MD route.

Best Scientists Citing Donald A. Berry

Trending Scientists

Recently Published Articles